Wuxi Seliwei Biotechnology Co., Ltd.

Product Name: Lenalidomide

English Name: Lenalidomide

CAS: 191732-72-6

Molecular formula: C13H13N3O3

Molecular weight: 259.26062

EINECS No. 1308068-626-2

Standard: enterprise standard

Natural/synthetic: synthesis

Extraction Source: Pricing

Level: pharmaceutical grade

Content: 99%

Appearance: white powder

Packaging: 1KG/Aluminum Foil Bag Separable

Category: Pharmaceutical raw materials

Industry: pharmaceutical raw materials

Field: Small Molecular Inhibitors

Extended Products: Lenadomide Capsules

Use: Multiple myeloma: Patients with multiple myeloma who have received at least one treatment with dexamethasone. 2. Myelodysplastic syndrome: for the treatment of transfusion-dependent aplastic anemia caused by myelodysplastic syndrome with 5q deletion cytogenetic abnormalities

Usage and dosage: 1. Multiple myeloma: every 28 days for a cycle, 1-21 days, take 25 mg Lenadomide capsule every day. In the first four cycles, 40 mg of dexamethasone was taken daily for the first 4, 9 12 and 17 20 days, and then 40 mg of dexamethasone was taken daily for the first 4 days of each cycle. 2. Myelodysplastic syndrome: The recommended initial dose is 10 mg per day.